Evaluation of the effect of ghamz with needle on improvement of respiratory symptoms of COVID-19 patients admitted to hospital

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2020
INTERVENTION: Intervention 1: Intervention group: In intervention group ghamz with needle will be performed at six points LU5, LU7 and SP6, symmetrically on both sides of the body, (points 5 and 7 of the lung path and point 6 of the spleen path) for 20 minutes daily for 7 days. In addition, patients receive conventional medical treatments according to the instructions issued by the Ministry of Health. Intervention 2: Control group: In control group sham therapy will be performed at six points LU5, LU7 and SP6, symmetrically on both sides of the body, (points 5 and 7 of the lung path and point 6 of the spleen path) for 20 minutes daily for 7 days. In addition, patients receive conventional medical treatments according to the instructions issued by the Ministry of Health. CONDITION: B34.2 Coronavirus infection. ; Coronavirus infection, unspecified PRIMARY OUTCOME: Body temperature (fever). Timepoint: Daily. Method of measurement: Thermometer. Cough. Timepoint: Daily. Method of measurement: Visual Analogue Scale (VAS). Dyspnea. Timepoint: Daily. Method of measurement: Visual Analogue Scale (VAS). Percentage of blood oxygen saturation. Timepoint: Daily. Method of measurement: Pulse oximeter device. Respiratory rate per minutes. Timepoint: Daily. Method of measurement: Using a vital signs monitoring device (heart monitoring). INCLUSION CRITERIA: The patient's coronavirus is approved by PCR test The patient is hospitalized. The patient agrees to participate in the study The respiratory rate of the patient is more than 30 times per minute Blood oxygen level should be less than 93% The patient have pulmonary infiltration according to chest x‐ray graph The patient does not afflict from any serious simultaneous heart, lung, brain, and endocrine disease The patient's ability and personal desire to fill out a personal consent form to enter the study
Epistemonikos ID: cbbb3ee858b3b0e01c03f6e58f7f11bf8918468c
First added on: Nov 02, 2020